Currently not for sale in the USA
Research Use Only
STIPlex MG +23S
The STIPlex MG+23S* is a qualitative 1-well, multiplex qPCR assay with improved detection for Mycoplasma genitalium and 5 mutations at positions 2058 and 2059 in the 23S rRNA gene associated with azithromycin resistance (A2058G, A2059G, A2058T, A2058C, and A2059C, Escherichia coli numbering).
The presence of any of these polymorphisms confers resistance to macrolide antibiotics (i.e., azithromycin). These components use PlexPCR® (PlexZyme® & PlexPrime®) technology.
Why use STIPlex MG +23S?
Provides 3 readouts
Readout 1 detects the Mycoplasma genitalium MgPa gene.
Readout 2 detects a A2058C/G/T or A2059C/G mutation in the Mycoplasma genitalium 23S rRNA gene.
Readout 3 is a control to monitor extraction efficiency and qPCR inhibition
Compatible with liquid handling systems, 96-well reaction formats
For Research Use Only
Amplification instruments
Thermo Fisher Applied Biosystems QuantStudio™ 5 and ABI QuantStudio™ 7
Shipping Conditions
Reagents — dry ice/ice packs
Storage & Stability
Store protected from light between -25ºC to -15ºC
Intended use
Research Use Only — not for use in diagnostic procedures
Resources
Specifications
Publications
We are committed to supporting continued scientific discovery and generation of clinically relevant data. Collaborations with key researchers and clinicians around the globe help us improve diagnostics and address urgent clinical needs.
Product | Compatible | Size | Catalog |
STIPlex MG +23S | ABI QuantStudio 5 and QuantStudio 7 | 100 reactions | 72022011 |
Accessory Products (Optional Positive Control) | |||
All Platforms | 10 reactions | 95001 | |